Product
Nucleoside/nucleotide reverse transcriptase inhibitors
1 clinical trial
1 indication
Indication
Chronic Hepatitis B InfectionClinical trial
A Multicenter, Randomized, Controlled Phase IIa Study to Evaluate the Antiviral Activity and Safety of HH-003 in Nucleos(t)Ide Analogues-treated Chronic Hepatitis B Subjects With Low-Level ViremiaStatus: Active (not recruiting), Estimated PCD: 2023-04-24